Literature DB >> 21119269

Osteosarcoma of the mandible--second cancer in a case of Hodgkin's lymphoma post-chemotherapy.

Sumitava De1, Suparna Ghosh, Dodul Mondal, Prabir K Sur.   

Abstract

Osteosarcoma as a second cancer occurring in an adolescent male previously treated with only chemotherapy for Hodgkin's lymphoma is rare. A 14 year old male presented with gradual swelling of right jaw and numbness of lip and chin for last three months. He was treated with only chemotherapy for Hodgkin's lymphoma four years back. Incisional biopsy was taken from mandibular swelling, histopathology suggesting osteosarcoma. Right hemimandibulectomy and reconstruction with metallic implant were done along with excision of right parotid lymph node. Chemotherapy was started with cisplatin and doxorubicin regimen. Absence of radiation as a risk factor and very young age of the patient presenting with a second cancer made this case a rarity and hence the case is being reported.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21119269     DOI: 10.4103/0973-1482.73349

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  3 in total

1.  Squamous cell carcinoma of the oral cavity in nonsmoking women: a new and unusual complication of chemotherapy for recurrent ovarian cancer?

Authors:  Timothy L Cannon; Dominic W Lai; David Hirsch; Mark Delacure; Andrea Downey; Alexander R Kerr; Michael Bannan; Eleni Andreopoulou; Tamar Safra; Franco Muggia
Journal:  Oncologist       Date:  2012-05-23

2.  Oral squamous cell carcinoma in a patient treated with long-term pegylated liposomal doxorubicin for recurrent ovarian cancer.

Authors:  Matteo Pezzoli; Maurizio Bona Galvagno; Guido Bongioannini
Journal:  BMJ Case Rep       Date:  2015-01-14

Review 3.  Primary and radiation induced skull base osteosarcoma: a systematic review of clinical features and treatment outcomes.

Authors:  Othman Bin Alamer; Ali S Haider; Maryam Haider; Navraj S Sagoo; Faith C Robertson; Eliel N Arrey; Salah G Aoun; Kenny Yu; Aaron A Cohen-Gadol; Tarek Y El Ahmadieh
Journal:  J Neurooncol       Date:  2021-05-17       Impact factor: 4.506

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.